Biologics
-
Biologics
Paragon 28 Launches BEAST™ Cortical Fibers Expanding its Biologics Portfolio
ENGLEWOOD, Colo., November 14, 2023–(BUSINESS WIRE)–Paragon 28, Inc. (NYSE: FNA) is pleased to announce the launch of its BEAST™ Cortical…
Read More » -
Biologics
Spine Biologics Market to hit USD 3.4 billion by 2032, says Global Market Insights Inc.
Spine Biologics Industry is projected to witness a CAGR of 4.3% during the period 2023-2032. This growth can be attributed…
Read More » -
Biologics
Xtant Medical Completes Acquisition of Surgalign’s Hardware and Biologics Business
BELGRADE, Mont., Aug. 10, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company…
Read More » -
Biologics
Xtant Medical Wins Auction for Surgalign’s Hardware and Biologics Business
Acquisition to Enhance Xtant’s Growing Spinal Fusion Devices Portfolio BELGRADE, Mont., July 28, 2023 (GLOBE NEWSWIRE) — Xtant Medical Holdings,…
Read More » -
Biologics
HippoFi’s PUR Biologics Granted National Approval at the Veterans Health Administration (VHA), the Largest Integrated Healthcare System in the United States
The nation’s largest system includes 1,298 healthcare facilities IRVINE, CA., June 28, 2023 / OrthoSpineNews / – HippoFi, Inc. (OTCPK:ORHB)…
Read More » -
Spine
Spine Biologics Market to Surpass USD 3.5 billion in 2033, expected to expand at a 4.2% CAGR: TMR Report
Increasing prevalence of spinal disorders and increase in geriatric population is driving the global spine biologics market. Demand for innovative…
Read More » -
Financial
Global Spinal Devices & Biologics Market Research Report to 2027 – Featuring Arthrex, Captiva Spine and Cure Surgical Among Others – ResearchAndMarkets.com
May 6, 2022 DUBLIN–(BUSINESS WIRE)–The “Spinal Devices & Biologics Market Research Report by Type (Fracture Treatment, Motion Preservation, and Non-Fusion Technologies),…
Read More » -
Biologics
RTI Surgical Announces Spin Off of Businesses into Two Independent Companies
Metals business will become Resolve Surgical Technologies Tissue & Biologics business will retain the RTI Surgical name ALACHUA, Fla., Jan. 4,…
Read More » -
Biologics
Fuse Medical, Inc. Announces Official Launch of FuseChoice™ Dermal Matrix
September 9, 2021 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of…
Read More » -
Biologics
Royal Biologics Announces Partnership with Vilex to Distribute Their ALC Technology Portfolio for Expansion of Biologics in Lower Extremity Procedures
HACKENSACK, NJ, August 17, 2021 /OrthoSpineNews/ – Royal Biologics, an Autologous and Live Cellular solutions-focused company, and Vilex, a leader…
Read More » -
Biologics
OrthoSpineNews Teams up with Spine IEP Fellows & Young Surgeons’ Course as Official Publication
San Diego, CA – June 24, 2021, – Magnifi Group, Inc., announced today that its Spine IEP Fellows & Young…
Read More » -
Biologics
Paragon 28® Inc., Expands its Novel Biologics Portfolio with Addition of Three Families of DBM
Introducing BEAST™ Injectable, BEAST PLUS™, and BEAST™ Osteobiologic Sponge (BOB™) for bone grafting applications in the foot and ankle. ENGLWOOD,…
Read More » -
Biologics
Global Spine Biologics Market to Reach $2. 3 Billion by 2027. Amid the COVID-19 crisis, the global market for Spine Biologics estimated at US$1. 9 Billion in the year 2020, is projected to reach a revised size of US$2
New York, Dec. 29, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Spine Biologics Industry” – https://www.reportlinker.com/p05960167/?utm_source=GNW3…
Read More » -
Biologics
Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio
December 22, 2020 RICHARDSON, Texas–(BUSINESS WIRE)–Fuse Medical, Inc. (OTCPINK: FZMD) (“Fuse” or the “Company”), an emerging manufacturer and distributor of…
Read More »